These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27994765)

  • 1. Discovery of Highly Potent Liver X Receptor β Agonists.
    Kick EK; Busch BB; Martin R; Stevens WC; Bollu V; Xie Y; Boren BC; Nyman MC; Nanao MH; Nguyen L; Plonowski A; Schulman IG; Yan G; Zhang H; Hou X; Valente MN; Narayanan R; Behnia K; Rodrigues AD; Brock B; Smalley J; Cantor GH; Lupisella J; Sleph P; Grimm D; Ostrowski J; Wexler RR; Kirchgessner T; Mohan R
    ACS Med Chem Lett; 2016 Dec; 7(12):1207-1212. PubMed ID: 27994765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates.
    Kirchgessner TG; Martin R; Sleph P; Grimm D; Liu X; Lupisella J; Smalley J; Narayanan R; Xie Y; Ostrowski J; Cantor GH; Mohan R; Kick E
    J Pharmacol Exp Ther; 2015 Feb; 352(2):305-14. PubMed ID: 25467132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.
    Kick E; Martin R; Xie Y; Flatt B; Schweiger E; Wang TL; Busch B; Nyman M; Gu XH; Yan G; Wagner B; Nanao M; Nguyen L; Stout T; Plonowski A; Schulman I; Ostrowski J; Kirchgessner T; Wexler R; Mohan R
    Bioorg Med Chem Lett; 2015 Jan; 25(2):372-7. PubMed ID: 25435151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decline of ATP-binding cassette transporter G1 expressions with a liver X receptor-independent pathway in patients with type 2 diabetes].
    Wang HJ; Zhao XS; Sun HY; Chen LF; Yan XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):899-905. PubMed ID: 25512280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
    Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
    Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E17110 promotes reverse cholesterol transport with liver X receptor β agonist activity in vitro.
    Li N; Wang X; Liu P; Lu D; Jiang W; Xu Y; Si S
    Acta Pharm Sin B; 2016 May; 6(3):198-204. PubMed ID: 27175330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.
    Hu B; Unwalla RJ; Goljer I; Jetter JW; Quinet EM; Berrodin TJ; Basso MD; Feingold IB; Nilsson AG; Wilhelmsson A; Evans MJ; Wrobel JE
    J Med Chem; 2010 Apr; 53(8):3296-304. PubMed ID: 20350005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
    Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
    Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.
    Tang SL; Chen WJ; Yin K; Zhao GJ; Mo ZC; Lv YC; Ouyang XP; Yu XH; Kuang HJ; Jiang ZS; Fu YC; Tang CK
    Atherosclerosis; 2012 Jun; 222(2):344-54. PubMed ID: 22503545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
    Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
    Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1.
    Cheng LC; Su KH; Kou YR; Shyue SK; Ching LC; Yu YB; Wu YL; Pan CC; Lee TS
    Free Radic Biol Med; 2011 Jan; 50(1):47-54. PubMed ID: 21034810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.
    Ullrich JW; Morris R; Bernotas RC; Travins JM; Jetter J; Unwalla R; Quinet E; Nambi P; Feingold I; Huselton C; Enroth C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 May; 20(9):2903-7. PubMed ID: 20382019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
    Zeng Y; Peng Y; Tang K; Wang YQ; Zhao ZY; Wei XY; Xu XL
    Biomed Pharmacother; 2018 May; 101():543-552. PubMed ID: 29505925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration.
    Hu B; Bernotas R; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wilhelmsson A; Nambi P; Evans M; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):689-93. PubMed ID: 19962892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
    Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.